Literature DB >> 22463828

Why does my patient have thrombocytosis?

Nanna H Sulai1, Ayalew Tefferi.   

Abstract

Thrombocytosis is a common clinical problem frequently encountered during routine evaluation. The diagnostic workup entails a step-by-step approach, which allows for an accurate assessment of the underlying cause. A thorough clinical history and physical examination may help differentiate thrombocytosis secondary to a reactive process versus an underlying clonal proliferation process. Once essential thrombocytosis is evident, relevant laboratory evaluation for an ongoing myeloproliferative disorder is paramount. Various treatment modalities have been proven to be beneficial. With further scientific investigation underway, molecular therapies may soon be cornerstones of therapy in essential thrombocytosis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22463828     DOI: 10.1016/j.hoc.2012.01.003

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  4 in total

1.  Plateletcrit. A platelet marker associated with saphenous vein graft disease.

Authors:  I Akpinar; M R Sayin; Y C Gursoy; T Karabag; E Kucuk; M C Buyukuysal; M Aydin; I C Haznedaroglu
Journal:  Herz       Date:  2013-04-12       Impact factor: 1.443

2.  Assessment of hepato-renal damage and genotoxicity induced by long-term exposure to five permitted food additives in rats.

Authors:  Khaled Abo-El-Sooud; Mohamed M Hashem; Yahia A Badr; Mona M E Eleiwa; Ali Q Gab-Allaha; Yasmina M Abd-Elhakim; Ahmed Bahy-El-Dien
Journal:  Environ Sci Pollut Res Int       Date:  2018-07-06       Impact factor: 4.223

3.  Is thrombocytosis always an indicator of autosplenectomy in patients with systemic lupus erythematosus?

Authors:  Döndü Üsküdar Cansu; Hava Üsküdar Teke; Ahmet Musmul; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2017-11-08       Impact factor: 2.631

4.  CCL5 derived from platelets increases megakaryocyte proplatelet formation.

Authors:  Kellie R Machlus; Kelly E Johnson; Rajesh Kulenthirarajan; Jodi A Forward; Mason D Tippy; Thomas S Soussou; Saleh H El-Husayni; Stephen K Wu; Suming Wang; Randolph S Watnick; Joseph E Italiano; Elisabeth M Battinelli
Journal:  Blood       Date:  2015-12-08       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.